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ABSTRACT 
 
Biochemical Markers of Bone Modeling and Remodeling in Juvenile Racehorses at  
 
Varying Mineral Intakes.  (May 2006) 
 
Elena Maria Eller, B.S., Texas A&M University 
 
Chair of Advisory Committee:  Dr. Pete Gibbs 
 
 
 
 Blood-borne biochemical markers were used to track comparative rates of bone 
turnover in horses fed differing amounts of Ca, P and Mg.  Bone turnover was tracked 
by serum osteocalcin, bone resorption by the carboxyterminal telopeptide of type I 
collagen (ICTP), and bone formation by the carboxyterminal propeptide of type I 
procollagen (PICP).  Twenty-four long-yearling Quarter Horses were blocked by gender 
and age, randomly assigned to one of four diets and subjected to 128 d of race training.  
Horses entered the study at approximately 20 months of age.  The study was conducted 
in 32-d periods, each consisting of 28 d of race training followed by a 4-d fecal and urine 
collection, or a 4-d rest period.  Blood samples were taken weekly during the training 
period.  Serum and plasma samples were analyzed for concentrations of osteocalcin, the 
carboxyterminal telopeptide of type I collagen (ICTP) and the carboxyterminal 
propeptide of type I procollagen (PICP).  Urine was collected for analysis of 
deoxypyridinoline (DPD) and creatinine.   
 Onset of training resulted in elevated concentrations of ICTP, PICP and 
osteocalcin.  Horses consuming the highest levels of Ca, P and Mg exhibited higher 
concentrations of PICP and lower concentrations of ICTP indicating greater bone 
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formation coupled with lesser amounts of bone resorption.  Further, ICTP, PICP and 
osteocalcin concentrations decreased dramatically following 4-d of confinement and 
relative inactivity.  Therefore it appears that feeding minerals at levels greater than 
current NRC recommendations provided a protective effect on the developing skeleton 
of the young racehorse.  Additionally, the biochemical markers used in this study were 
sensitive enough to track daily changes in bone activity resulting from daily changes in 
stress to the skeleton. 
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CHAPTER I 
INTRODUCTION  
 
The incidence of skeletal injuries to young racehorses is a significant problem in 
the horse industry.  These injuries are not only expensive in terms of direct veterinary 
costs, but in loss of opportunity for training and competition as well.  Feeding and 
training mismanagement early in life are thought to contribute to the high frequency of 
injury in juvenile equine athletes.  Juvenile racehorses entering training undergo a period 
of bone demineralization followed by a period of remineralization.  While this process of 
remodeling is necessary for the skeleton to adapt to physical strain, the onset of speed 
work (50-60 d into training) often appears to coincide with the period of greatest bone 
demineralization (Nielsen et al., 1997).  Thus, the bone is being subjected to excessive 
strain at a point when it is least prepared to handle that strain.  A study by Nielsen et al. 
(1998) demonstrated that feeding Ca and other minerals at 30% above NRC (1989) 
recommendations to young Quarter Horses in race training reduced the extent of 
demineralization during the remodeling process.  Further, Nielsen et al. (1997) found 
that horses that started with more bone were less likely to experience injury during 
training.   
Proper bone development is dependant on both proper nutrition and the correct 
amount of physical activity.  Research has repeatedly shown that a certain amount of 
exercise is necessary for the bone to remodel in order to withstand the strain that will be 
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placed on it later in life.  However, excessive loading at a time when the bone is not 
prepared to handle that strain can result in injury. Additionally, current literature 
indicates that the NRC (1989) recommendations for young horses in training are 
insufficient for maximizing bone growth and preventing skeletal injuries.  Several 
studies have reported that feeding Ca and other minerals at levels greater than NRC 
(1989) recommendations during the time of training can be beneficial.  Thus, a better 
understanding of how to feed and manage young horses in race training is needed in 
order to help better prepare the bone to withstand the intensity of training and racing. 
The purpose of this study was 1) to evaluate the use of biochemical markers to 
track comparative rates of bone turnover, bone resorption, and bone formation in 
juvenile horses in race training and 2) to assess the impact of varying concentrations of 
Ca, P and Mg on bone activity. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
The majority of career-ending injuries to racehorses involve the skeleton 
(Johnson, 1993).  It has been documented that more than 50% of 2-year-old racehorses 
experience some form of injury during training (Jones et al., 1989; Rossdale et al., 
1985).  Several studies have reported that skeletal maturation and maximal bone density 
and mineral content are not reached until 4-6 years of age (Buckingham et al., 1992; 
Lawrence et al., 1994).  Additionally, inertial properties of the third metacarpal change 
dramatically from 1 to 3 years of age, but changes are lesser past three years of age 
(Nunamaker et al., 1989).  Starting long-yearling horses in training is often criticized 
because of the high occurrence of injury and the idea that immature bone is not prepared 
to withstand the stresses of racing; however, the skeleton of the young animal is more 
adaptable to training than the skeleton of the mature animal, thus this may be the optimal 
time to introduce training.  Mansell et al. (1999) demonstrated that younger horses had a 
greater ability to respond to exercise following a period of idleness than did older horses.  
Additionally, a study of racing careers of horses in Australia, although not conclusive, 
demonstrated that horses that raced as 2-year-olds had a greater number of starts and 
raced in more seasons than horses that started racing as 3-year-olds (Bailey et al., 1999).   
Bone is a unique tissue in that, although rather rigid, it responds fairly quickly to 
patterns of strain in the external environment.  The ability of bone to alter its mass and 
shape according to the load that is placed upon it was first described in the nineteenth 
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century by J. Wolff (Duncan and Turner, 1995).  Wolff’s law has been used to describe 
the ability of exercise to enhance bone strength and has been widely demonstrated in 
numerous species.  Cells within the bone detect variations in mechanical strain that fall 
outside the physiological window activating processes that alter the extra-cellular matrix 
of bone tissue in order to return strain to a desired level and prevent failure.  When 
mechanical signals exceed the upper boundary of the physiological window, also known 
as the minimum effective strain, the bone undergoes changes in its structure in order to 
reduce strains back to a level below the upper boundary (Duncan and Turner, 1995).  
Conversely, disuse or decreased activity causes the unneeded bone mass to be removed 
through resorption (Iwamoto et al., 2000).  Bone mineral content has been shown to 
decrease in weanlings and yearlings that are confined to stalls compared to those left out 
on pasture (Hoekstra et al., 1999; Bell et al., 2001).   
Several studies in horses have demonstrated that exercise initiates skeletal 
adaptations.  Schryver et al. (1978) found that bone from young exercised ponies tended 
to be stiffer and have a greater breaking strength than samples taken from age-matched 
controls.  Sherman et al. (1995) found that cortical area and dorsopalmer bone diameter 
increased with duration of training in bones taken from 24 to 48 month-old 
Thoroughbred horses in race training.  Increased dorsal cortical thickness in response to 
maximal exercise has been documented in two studies of yearling horses by McCarthy 
and Jeffcott (1991, 1992). 
Bone modeling is site specific involving either addition of mineral to the site in 
order to increase bone density, or the removal and addition of bone to change the shape 
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of the bone (often referred to as remodeling).  Growing and adult skeletons respond 
differently to mechanical stimuli (Bieweiner and Bertram, 1993).  In the growing, 
exercising animal, adaptation of bone is most likely more of a change in bone geometry, 
as the primary factor influencing strength of long bones is moment of inertia or shape 
(Whalen et al., 1993).  Thus, changing the shape of the bone results in a stronger 
structure than simply adding density.  Research has shown that exercise training can 
result in increased cross sectional area of bone, increase in cortical thickness, or change 
in size of the medullary cavity (Woo et al., 1981).  The drop in bone mineral density in 
horses over 6 months of age corresponds to replacement of primary bone through 
resorption (Stover et al., 1992).  Further, Cornelissen et al. (1999) reported an increase in 
cross sectional area of the third metacarpal of horses between 5 and 11 months of age 
concurrent with a decrease in bone mineral density.  A study by Sherman et al. (1995) 
found a positive correlation between duration of training and area moment of inertia, 
cortical area, and dorsopalmer bone diameter in bones taken from young racehorses.  
Additionally, most of the increase in the cross sectional area of bone was due to 
thickening in the dorsal cortex.  Riggs and Boyde (1999) found that increased bone 
density in the distal region of the third metacarpal in long-yearlings in training was due 
to new bone formation.   
While it has been shown that exercise can increase the strength of the skeleton, 
overloading the bone can result in increased risk of fracture.  Fatigue due to repetitive 
loading causes micro-cracks, which can accumulate to dangerous levels if the skeleton is 
not provided enough time to repair itself.  These micro-cracks, commonly referred to as 
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“bucked shins” or dorsal metacarpal disease, have been reported to occur in 70 to 80% 
of two-year-old racehorses (Norwood, 1978), and in the past, were thought to be a 
normal part of the training process.  Accumulation of micro-damage can result in failure 
of the bone at strains that are within the physiological window (Burr et al., 1985).  The 
presence of micro-cracks causes the bone to become less stiff, which magnifies the strain 
(Nunamaker et al., 1990) and initiates the repair mechanism of bone remodeling (Mori 
and Burr, 1993).  During remodeling, the weakened bone is removed and replaced with 
new bone.  The removal of the old bone causes a temporary increase in the porosity of 
the bone thus further increasing the susceptibility to failure. 
Regardless of the stimuli, bone remodeling is an organized process that begins 
with bone resorption and ends with new bone formation.  Resorption begins with 
recruitment of preosteoclasts, followed by differentiation into mature osteoclasts that 
then attach to the skeletal surface (Kleerekoper, 1996).  During resorption (or 
demineralization) mineral is removed from the skeleton creating a cavity in the bone, 
which results in greater porosity and decreased bone strength.  Thus there is a greater 
chance for micro-cracks to occur at the same strain.  It is during this time that repetitive 
loading or an increase in the magnitude of loading can result in fatigue failure (Neilsen 
et al., 1997).  While demineralization proceeds, preosteoblasts are recruited to the region 
where they mature into osteoblasts and attach to the base of the newly formed cavity 
(Kleerekoper, 1996).  The osteoblasts synthesize and secrete the organic matrix that will 
become mineralized and form the new osteon (Parfitt, 1984).  During the entire 
remodeling process, resorption and formation are tightly coupled, with resorption 
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proceeding rapidly followed by the much slower progression of the formation phase.  In 
the event of skeletal repair, such as in response to micro-cracks, the amount of new bone 
formed is identical to the amount of bone removed resulting in zero net change.  
Conversely, during processes such as growth, bone formation exceeds resorption 
whereby a positive skeletal balance results from each remodeling cycle (Kleerekoper, 
1996).  Thus, an appropriate exercise program is important in order to achieve properly 
adapted bone while avoiding fatigue failure during the time when the bone is at its 
weakest. 
The equine skeleton is composed of approximately 35% Ca, 15% P and 0.5% 
Mg.  Interactions between these minerals and proper amounts in the diet are important in 
maximizing the potential strength of the skeleton.  Ca is directly implicated to bone 
through incorporation into the hydroxyapetite (Porr et al., 2000) and Ca intake is 
important in the development of peak bone mass.  Low Ca intake in humans has been 
associated with low bone mass (Weaver, 2000) and Ca supplementation has been shown 
to positively influence peak bone mass (Abrams and O’Brien, 2004).  Ca deficiency in 
children is related to bone mineral insufficiency (Abrams and O’Brien, 2004) and in 
young horses has been linked with metabolic bone disease (NRC, 1989).   
Like Ca, P is also a major constituent of bone.  Inadequate dietary P may be 
linked with bone demineralization in horses (Lawrence et al., 1994).  However, it is 
important that P levels in the diet not be allowed to exceed Ca levels as ratios of Ca:P 
less than 1:1 appear to inhibit Ca absorption (NRC, 1989).  Although Mg does not 
comprise as great a percentage of bone as do both Ca and P, 60% of the Mg in the body 
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of the horse is found in bone (NRC.  Mg deficiency has been shown to induce 
uncoupling of bone formation and resorption in the rat leading to loss of bone mass 
(Rude et al., 1999).   
The mineral requirements for juvenile equine athletes are largely unknown.  The 
most widely used publication for formulating horse rations is the National Research 
Council’s Nutrient Requirements for Horses.  The most recent NRC publication has 
significant limitations particularly in regard to young horses in training.  In the absence 
of scientific data, recommendations for growing, exercising horses were extrapolated 
from data obtained from horses at rest.  Recent research has demonstrated that these 
recommendations may be inadequate for maximizing bone development and preventing 
injuries during race training.  Studies conducted by Schryver et al. (1978) and Young et 
al. (1989) have shown decreased urinary Ca and greater Ca retention when horses are 
exercised versus sedentary.  Gray et al. (1988) found that horses in training had lower Ca 
excretion than horses not in training, despite receiving more Ca in the diet.  In a study by 
Neilsen et al. (1998), horses in training receiving higher levels of Ca had greater Ca 
retention.  Greater mineral content of the third metacarpal was seen in young race horses 
fed Ca at 151% to 169% of NRC (1989) recommendations (Nolen et al., 2001).  Unlike 
Ca, an increased demand for P during exercise has not yet been clearly demonstrated.  
Young et al. (1989) reported increases in P retention in exercising horses.  Conversely, 
Neilsen et al. (1998) found no change in P retention in young horses put into race 
training despite varying P concentrations in the diets.  In the same study, Mg retention 
increased after three months of training along with mineral density of the third 
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metacarpal in horses provided with Ca supplementation.  The authors hypothesized that 
increased Mg retention was caused by the increased bone formation resulting from 
increased Ca in the diet.  The majority of the work done in Mg nutrition for exercising 
horses is confounded by varying concentrations of Ca and P.  However, it seems that 
exercise and stage of training have some influence on Mg requirements (Stephens et al., 
2001).   
An important area of study in recent years has been the development of non-
invasive techniques for studying the synthesis and degradation of bone.  Significant 
progress in the development of biochemical markers for the assessment of bone 
metabolic activity has been driven by research in human osteoporosis.  Several of these 
markers have proven useful in horses (Price et al., 1995a; Lepage et al., 2001).  During 
bone formation, osteoblasts synthesize non-collagenous protein and type I collagen, 
which are partially secreted into the bloodstream (Lepage et al., 2001).  Osteocalcin, also 
known as bone gla-protein (BGP), is non-collagenous, bone-specific protein that has 
been used extensively as a bone formation marker in past studies.  Predominately 
synthesized by osteoblasts, osteocalcin is incorporated into the extracellular matrix, but a 
small fraction is released into circulation where it can be measured (Garnero and 
Delmas, 1996).  However, since osteocalcin is part of the bone matrix, it is released into 
circulation during the resorptive phase as well (Kleerekoper, 1996).  Additionally, it has 
been documented that BGP may also serve to regulate osteoclastic recruitment and 
regulation (Rodan and Rodan, 1995).  Research has shown that when resorption and 
formation are uncoupled, osteocalcin is indeed a specific bone formation marker.  Yet 
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when resorption and formation are coupled, serum levels at any one time contain 
components of both formation and resorption (Kleerekoper, 1996) therefore osteocalcin 
may better be interpreted as indicative of overall bone turnover (Garnero and Delmas, 
1996).  In addition to osteocalcin, there are several other markers of bone activity based 
on the metabolism of type I collagen which is the sole collagen in the organic matrix of 
bone.  During the conversion of type I procollagen to collagen, there is a cleavage of the 
carboxyterminal propeptide (PICP) from the carboxy-terminal end of the protein during 
posttranslational modification, which is then released into circulation (Melkko et al., 
1990).  Concentrations of PICP exist in a stoichiometric relationship to the molecules of 
type I collagen formed thus, serum PICP is used as an indicator of bone formation.   
As collagen is incorporated into collagen fibers, cross-links are formed between 
the terminal, non-helical propeptide of one collagen molecule to the helical region of 
another collagen molecule.  During resorption, these cross-linked peptides, known as the 
carboxyterminal telopeptide of type I collagen (ICTP), are released into circulation.  
Thus, ICTP is used a marker for bone resorption (Eriksen et al., 1993).  An additional 
marker released from the bone matrix during degradation by osteoclasts is 
deoxypyridinoline (DPD).  DPD is one of the two nonreducible pyridinium crosslinks 
present in collagen that serves to stabilize the collagen molecule (Lepage et al., 2001).  
These crosslinks cannot be reutilized in collagen synthesis and are not metabolized in 
vivo therefore they are excreted in the urine (Garnero and Delmas, 1996).   
Many studies have shown the potential use of these markers in horses for 
tracking skeletal growth and development, and for studying the effects of factors such as 
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training and nutrition on skeletal adaptation (Price et al., 1995b; Price, 1998; Hoekstra et 
al., 1999; Hiney et al., 2000).  Although biochemical markers are not suited to predict 
bone mass, they have been correlated with changes in bone mass and it has been 
suggested that they could be useful in predicting fracture risk.  In humans these markers 
are successfully used to monitor effectiveness of osteoporosis therapy in patients 
(Kleerekoper, 1996).  More recently, studies in humans have indicated that these 
markers can predict patients at risk of osteoporotic fracture (Ebeling and Akesson, 
2001).  Jackson et al. (2005) conducted a study of 165 2-year-old racehorses to 
determine the relationship between serum concentrations of bone markers early in the 
training season and development of dorsal metacarpal disease (DMD).  The authors 
found that ICTP concentrations early in the training season were significantly higher in 
horses that subsequently developed DMD.  Although not proven, it is conceivable that 
with enough research, these markers could be independently used to predict fracture risk 
in elite equine athletes. 
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CHAPTER III 
MATERIALS AND METHODS 
 
Management of Animals 
Twenty-four long yearling Quarter Horses were blocked by gender and age, and 
randomly assigned to one of four diets.  Horses were staggered so as to enter the study at 
20 months of age.  All horses were gathered at the Texas A&M Horse Center where they 
were vaccinated and de-wormed prior to entering the study.  Animals were then 
transported to Steephollow Farm where they were individually housed in 4X4 meter 
stalls.  Routine hoof care and parasite control was performed as necessary throughout the 
trial.  All procedures for animal care and use for this study were reviewed and approved 
by the Texas A&M University Agricultural Animal Care and Use Committee. 
 
Experimental Diets 
The four experimental diets were formulated to contain varying levels of Ca, P 
and Mg while meeting or slightly exceeding NRC (1989) recommendations for all other 
nutrients (Table 1).   
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Table 1.  Calculated nutrient profiles of the concentrates (as fed basis)a
Nutrient Diet A Diet B Diet C Diet Db
Dry Matter, % 85.9 86.1 86.3 86.3
Protein, % 14.1 14 14.1 14.1
Crude Fat, % 5.1 5.1 5.0 5.0
Crude Fiber, % 2.1 3.2 3.4 5.4
DE, kcal/kg 3212 3115 3065 2924
Calcium, % 0.48 0.55 0.81 0.85
Phosphorus, % 0.25 0.30 0.44 0.52
Magnesium, % 0.12 0.15 0.22 0.23
Potassium, % 0.51 0.69 0.74 0.84
Salt, % 0.48 0.76 0.75 0.75
Sulfur, % 0.17 0.18 0.19 0.18
Total Copper, ppm 57 57 57 58
Total Iron, ppm 90 90 130 96
Total Manganese, ppm 76 84 91 127
Total Zinc, ppm 127 131 135 160
Added Cobalt, ppm 0.2 0.2 0.2 0.2
Added Copper, ppm 51 51 51 51
Added Iodine, ppm 0.1 0.1 0.1 0.1
Added Iron, ppm 29 29 29 29
Added Manganese, ppm 66 66 66 66
Added Selenium, ppm 0.3 0.3 0.3 0.3
Added Zinc, ppm 111 111 111 111
Vitamin A, IU/kg 84.18 84.18 84.18 84.18
Vitamin D, IU/kg 12.65 12.65 12.65 12.65
Vitamin E, IU/kg 144.8 144.8 144.8 144.8
Added Riboflavin, mg/kg 5.6 5.6 5.6 5.6
Added Thiamin, mg/kg 10.5 10.5 10.5 10.5
Lysine, % 0.76 0.76 0.76 0.76
aCalculated by Consolidated Nutrition, Ltd, Omaha, Nebraska
bPatriot 14-P, Consolidated Nutrition, Ltd., Omaha, Nebraska  
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An additional constraint for formulation of the diets was that the ratio of 
CA:P:Mg would be 3.5:2:1.  It should be noted that diet D was a commercially available 
diet manufactured by Consolidated Nutrition, Ltd., Omaha, Nebraska.  All concentrates 
were formulated, mixed and bagged by Consolidated Nutrition.  Table 2 shows 
formulated nutrient profiles of the four diets as provided by Consolidated Nutrition.  The 
total diet consisted of 40% coastal Bermudagrass hay and 60% of the assigned pelleted 
concentrate.  All horses were backgrounded for a minimum of 1 week at the Horse 
Center were they were group housed in dirt-lot pens before being transported to 
Steephollow Farm.  During this time, each horse received Diet D at approximately 2% of 
the average weight of the pen per day.  Once they entered the study, the horses were 
individually fed their assigned diets at 12-hour intervals (0700 and 1900).  The animals 
were given the entire 12 hours to consume the meal and any feed refusals were weighed 
and recorded.  Adjustments in feed intake were made in order to maintain body 
condition between and score 5 to 6 and in order to allow for normal growth.  
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Training of Animals 
The study was conducted in four, 32-day periods, each consisting of 28 days of 
race training followed by either a 4-day total fecal and urine collection or a 4-day rest 
period.  The training protocol was designed to represent a typical commercial training 
regimen for racing Quarter Horses.  During the first week, horses were ridden in a round 
pen and then moved to the track by the middle of the first week, depending on individual 
temperaments.  For the first 3 days, horses were walked for 550 m, trotted for 110 m and 
galloped for 275 m.  The distance galloped was increased 275 m per day for each day 
Table 2.  Calculated mineral concentrations of diets (DM basis)a
% Calcium % Phosphorus % Magnesium
Concentrations in total diet
  (60:40 concentrate:hay):
Diet A 0.41 0.24 0.11
Diet B 0.48 0.29 0.13
Diet C 0.55 0.32 0.17
Diet D 0.63 0.40 0.18
Bermudagrass
IFN# 1-09-209 0.30 0.19 0.11
Contribution from Bermudagrass
  (40% of total diet) 0.12 0.08 0.04
Contribution from concentrate
portion (60% of total diet):
Diet A 0.29 0.16 0.07
Diet B 0.36 0.21 0.09
Diet C 0.43 0.24 0.13
Diet Db 0.51 0.32 0.14
aCalculated by Consolidated Nutrition, Ltd, Omaha, Nebraska
bPatriot 14-P, Consolidated Nutrition, Ltd., Omaha, Nebraska
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after day 3 so that the horses were galloping a total of 1375 m by the end of week 1.  
During weeks 2 through 4 of the first period, horses were ridden 5 days per week at the 
same distances for the walk and the trot, but the gallop was increased to 8250 m.  During 
the second period, the horses were ridden 4 days per week and the gallop was increased 
to 8440 m.  In period 3, the horses were again ridden 4 days per week, with one of those 
days being designated as a sprint day.  On sprint days, the horses were warmed up, 
sprinted for 230 m and then galloped.  On non-sprint days, the horses were trotted 550 m 
and galloped 1925 m.  During this time, the horses were galloped a total of 8210 m per 
week.  Period 4 continued as in period 3 except the sprints were increased to 275 m and 
the gallop was decreased to a total of 8165 m per week.  On rest days, the horses were 
walked for a minimum of 60 minutes on a mechanical walker. 
 
Physical Measurements 
Physical measurements of the animals were taken initially, and at 14-day 
intervals to monitor growth and analyze changes from pre-trial values.  These 
measurements included body weight, body length, heartgirth circumference, height at the 
withers and hip, circumference of the forearm and gaskin and rump fat thickness.  All 
measurements were taken in duplicate.  Weight was determined using a certified 
livestock scale.  Measurements of the heartgirth, forearm, gaskin and body length were 
taken using a plastic measuring tape.  Placement markings were made by clipping the 
animal’s hair, in order to ensure repeatability of the measurements.  Heartgirth was 
determined using the top of the withers for placement of the measuring tape.  Body 
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length was measured from the tuber ischii to the lateral tuberosity of the humerous.  
Height measurements were taken using a leveled height stick with the horse standing 
squarely on a flat, level surface.  Rump fat thickness was determined using ultrasound at 
a point that was half way between the point of the hip and the point of the rump. 
 
Sample Collection 
Immediately prior to entering the study, and during the last 4 days of periods 2 
and 4, horses were confined to tie stalls during which total urine and fecal output were 
collected.  Feces were collected immediately upon defecation from a rubber mat placed 
beneath each horse.  Every 3 hours, collections were thoroughly mixed, weighed and 
10% aliquot was obtained and stored at - 20°C for later analysis.  Urine was obtained via 
a standard urine collection harness.  Urine output was quantified every 4 hours and a 
10% sample was taken, strained through 4 layers of cheesecloth and stored at - 20°C for 
later analysis.  During the total collection periods (beginning on d - 4, 60 and 124), 
horses were walked for 60 minutes daily on a mechanical walker in lieu of racetrack 
exercise.  During this time urination was discouraged and any fecal matter was weighed 
and added to the daily totals, however none was added to the pooled sample.  Hay and 
feed samples were taken daily during the collection periods.  Fasting blood samples were 
taken prior to the morning meal at d - 4 (baseline), biweekly during periods 1 and 4 and 
weekly during periods 2 and 3.  Additional blood samples were taken at the end of each 
4-d rest period or total collection.  All blood samples were collected at the same time 
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each day and were processed within 4 h of collection.  Plasma and serum were harvested 
and stored at - 20°C for later analysis. 
 
Analyses of Samples 
Mineral analysis of feed, fecal and urine were conducted as part of a companion 
study (Stephens, 2002).  Feed, hay and fecal samples were dried in a forced air oven at 
62°C for 72 hours and ground in a Wiley mill with a 1 mm screen.  Dried samples were 
digested using a perchloric acid digestion procedure and suspended in deionized, 
distilled water.  Corn stalk reference material #8412 obtained from the National Institute 
of Standards and Technology was taken through each digestion and used as a control for 
mineral analysis.  Ca and Mg concentrations in feed, fecal and urine samples were 
determined by atomic absorption spectrophotometry.  Inorganic P was determined by 
colorimetry by the method of Fiske and Sabbarow (1925) using an Ultraspec III UV 
spectrophotometer.  Mineral absorption and retention was determined by difference 
using mineral intake and excretion data.   
Urine samples were analyzed for deoxypyridinoline by a solid-phase, 
chemiluminescent enzyme immunoassay using the Immulite® Pyrilinks-D kit from 
Diagnostic Products Corporation, Los Angeles, CA.  In order to standardize 
deoxypyridinoline concentrations, urine was additionally analyzed for creatinine 
concentrations by colorimetry using the Ultraspec III UV spectrophotometer.  Assay kits 
for creatinine were obtained from Sigma Diagnostics, Inc, St. Louis, MO.  Plasma 
samples were analyzed for osteocalcin concentrations by radioimmunoassay (RIA) using 
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kits from DiaSorin, Stillwater, MN.  Serum samples were analyzed for concentrations of 
the carboxyterminal telopeptide of type I collagen (ICTP) and the carboxyterminal 
propeptide of type I procollagen (PICP) by RIA using kits from DiaSorin.  Amount of 
radioactive material was determined using a Packard Cobra II gamma counter.  Inter- 
and Intra-assay coefficients of variations were determined using controls provided with 
the kits.   
 
Statistical Analyses 
Data were analyzed for group, day and group-by-day effects by analysis of 
variance using Stata Software (Stata Corp. 2001. College Station, TX).  Where 
necessary, means were further separated using a Fisher-Hayter means comparison test.  
In order to visualize and analyze changes from baseline, data for each horse were 
normalized to baseline (day - 4) values. Data for physical measurements taken at d - 4 
and d 128 were compared overall and by group using paired t-tests.  In addition, linear 
regression with fixed time effects was used to identify the underlying relationship 
between mineral intake and biochemical markers.  To facilitate interpretation, marginal 
effects in the form of elasticities were calculated for the model, setting all independent 
variables at the mean (Gujarati, 1999). 
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CHAPTER IV 
RESULTS  
 
Feed Intake 
 Total feed intake increased from d 0 to d 128 of the trial (Table 3).  The increase 
in total feed intake can be explained by the increase in weight that was also seen in the 
horses as feed intake per body weight did not change throughout the trial.  Feed intake 
corrected for body weight, and digested dry matter intake did not change significantly 
throughout the trial (Table 3).   
 
 
 
 
Table 3.  Feed intake and digestibility by day of trial (DM basis)
D 0 D 64 D 128
Total Feed Intake (kg)   6.91a   7.48b  7.93b
  SEM 0.25 0.36 0.23
Total Feed Intake (g/kg BW) 18.28 18.54 18.23
  SEM  0.76  0.79   0.50
Total Digested Dry Matter Intake (kg)   4.89   5.03   5.27
  SEM  0.19  0.23   0.14
Total Digested Dry Matter (g/kg BW) 12.94 12.47 12.14
  SEM   0.54   0.49   0.31
a,bRows means not sharing common superscripts differ (P<0.05)
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There were significant differences in feed intake among the diet treatments 
(Table 4).  Horses on diets A and C consumed less feed per day on average than did 
horses on diets B and D (P<0.05).  However, when corrected for body weight, horses on 
diet C consumed significantly less (P<0.05) than the other groups (Table 4).  Digested 
dry matter intake followed the same trends. 
 
 
 
Feed Analysis 
 Analyzed values for the Bermudagrass hay were similar to NRC (1989) values 
(Table 5).  However, analyzed mineral concentrations in the concentrates were different 
from formulated values (Table 6).  The analyzed Ca concentration in concentrates A and 
D (Patriot 14-P, Consolidated Nutrition) were less than formulated values while the 
concentration in concentrate B was greater than formulated values.  Although designated 
as the high mineral diet, the concentrate used in diet D contained less Ca than did both 
Table 4.  Feed intake and digestibility by diet treatment (DM basis)
Diet A Diet B Diet C Diet D
Total Feed Intake (kg)   6.52a  8.26b  6.88a  7.97b
  SEM  0.34 0.30 0.27 0.21
Total Feed Intake (g/kg BW) 17.59a 19.65a 16.66b 19.96a
  SEM  0.94  0.59  0.73  0.52
Total Digested Dry Matter Intake (kg)   4.58a   5.93b   4.71a   5.18a
  SEM  0.21  0.20  0.18  0.12
Total Digested Dry Matter (g/kg BW)    12.35a,b 13.70a   11.42b   13.01a
  SEM  0.62  0.42   0.51   0.40
a,bRow means not sharing common superscripts differ (P<0.05)
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concentrates B and C.  In the total diet, this resulted in a much narrower range in Ca 
concentrations among the treatments than was intended (Table 7).  Phosphorus 
concentrations in all four concentrates were far less than formulated values (Table 7).  
This again resulted in a much narrower range in P concentrations among the diets.  
Analyzed Mg concentrations were similar to formulated values in the feeds and an 
acceptable range in Mg was achieved among the total diets (Table 7).   
 
 
 
 
 
 
 
 
 
 
Table 5.  Formulated versus analyzed mineral concentrations in
Bermudagrass hay (DM basis).
% Calcuim % Phosphorus %Magnesium
Bermudagrass 0.30 0.19 0.11
IFN# 1-09-209
Analyzed Bermudagrass 0.32 0.15 0.11
(Stephens, 2002)
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Groupings by Intake  
The differences in analyzed mineral concentrations coupled with the differences 
in dry matter intake made reporting the data by use of assigned diets illogical.  
Therefore, data from all horses were arranged by Ca intake and horses were divided 
across diets into groups that corresponded to actual amounts of minerals consumed.  The 
intake groups were designated as low (L), moderate (M), moderate-high (MH) and high 
(H) reflecting different mineral intakes (Table 8).  The low group consumed an average 
Table 6.  Formulated (F) versus analyzed (A) mineral concentrations in
the concentrate (DM basis).
F A F A F A
Concentrate A 0.48 0.44 0.26 0.19 0.12 0.12
Concentrate B 0.60 0.64 0.35 0.33 0.15 0.14
Concentrate C 0.71 0.72 0.40 0.34 0.22 0.18
Concentrate D 0.85 0.55 0.54 0.36 0.23 0.19
(Stephens, 2002)
% Calcium % Phosphorus % Magnesium
Table 7.  Formulated (F) versus analyzed (A) mineral concentrations in the
total diet (DM basis)
F A F A F A
Diet A 0.41 0.39 0.24 0.17 0.11 0.11
Diet B 0.48 0.51 0.29 0.26 0.13 0.13
Diet C 0.55 0.56 0.32 0.26 0.17 0.15
Diet D 0.63 0.46 0.40 0.28 0.18 0.16
% Calcium % Phosphorus % Magnesium
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of 87.4 mg/kg BW⋅d-1 of Ca, 31.4 mg/kg BW⋅d-1 of P and 19.6 mg/kg BW⋅d-1 of Mg.  
The moderate group consumed on average 122 mg/kg BW⋅d-1 of Ca, 49 mg/kg BW⋅d-1  
of P and 28.8 mg/kg BW⋅d-1 of Mg.  The moderate high group consumed on average 
136.3 mg/kg BW⋅d-1 of Ca, 65 mg/kg BW⋅d-1 of P and 36.8 mg/kg BW⋅d-1 of Mg.  The 
high intake group consumed 153 mg/kg BW⋅d-1 of Ca, 66.3 mg/kg BW⋅d-1 of P and 37.8 
mg/kg BW⋅d-1 of Mg (Table 8).  Calcium intakes for the L, M, MH and H groups were 
97%, 138%, 155% and 170% of NRC (1989) recommendations, respectively.  Intakes of 
P and Mg ranged from 81% to 100% and 89% to 167% of NRC (1989) 
recommendations, respectively. 
 
 
 
 
Table 8.  Mineral consumption for horses grouped by calcium intake (mg/kg BW/d)
Calcium Phosphorus Magnesium
Low   87.4 31.4 19.6
  SEM   13.6   8.3   4.2
Moderate 122.0 49.0 28.8
  SEM     2.9   7.4   5.0
Moderate High 136.3 65.0 36.8
  SEM     4.8   4.1   2.5
High 153.0 66.3 37.8
  SEM     8.8   5.2   4.0
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Physical Measurements 
 Physical measurements were similar between the groups at d 0 and at d 128  
(Table 9).  The horses in the low mineral intake group gained significantly less (P<0.05) 
weight with an average gain of 37.50 kg when compared to horses in the high group that 
had an average gain of 65.22 kg.  There were no differences between the groups in gain 
of wither height, hip height, body length, heartgirth circumference or rump fat thickness 
(Table 9).   
 
 
 
Table 9.  Influence of diet and training on parameters of growth
Low SEM Moderate SEM Mod-High SEM High SEM
Weight, kg
  Initial 390.80 23.81 386.90 18.69 382.99 15.39 368.80 8.96
  Final 428.30 22.49 438.66 14.40 443.65 15.63 434.02 7.66
  Gain     37.50a   7.27      51.76a,b  5.50      60.57a,b  6.88     65.22b 7.27
Wither Height, cm
  Initial 144.91 2.40 148.08 0.58 148.33 1.59 148.70 1.25
  Final 148.97 2.17 152.02 0.95 153.93 1.37 152.09 1.39
  Gain     4.06 0.95     3.94 0.61     5.59 0.97     3.39 0.71
Hip Height, cm
  Initial 150.62 2.37 152.90 0.95 153.42 1.37 151.77 0.89
  Final 153.20 2.50 156.05 0.91 155.58 1.80 154.63 1.08
  Gain     2.70 0.79     2.38 0.65     2.16 0.97     2.16 0.32
Body Length, cm
  Initial 162.69 3.65 161.86 2.64 166.56 3.17 161.66 1.59
  Final 169.22 2.70 168.09 2.56 169.55 3.37 165.21 1.55
  Gain     6.54 2.00     6.22 1.07     2.98 1.67     3.55 1.85
Heartgirth, cm
  Initial 169.29 2.96 170.50 1.33 170.34 2.69 170.13 1.74
  Final 172.34 2.21 174.75 1.40  175.51 2.32 176.90 1.21
  Gain     3.05 1.52     4.26 1.16      5.18 1.36     6.78 1.39
Rump Fat, mm
  Initial 4.40 0.92 3.90 0.87 3.60 0.64 3.58 0.68
  Final 3.90 0.33 4.60 0.67 3.85 0.79 4.80 0.88
  Gain     -0.50 1.20 0.70 1.11 0.25 1.08 1.25 0.67
a,bRow means not sharing common superscripts differ (P<0.05)
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Urinary Deoxypyridinoline Crosslinks 
   Deoxypyridinoline (DPD) concentrations were expressed relative to creatinine 
concentrations in order to standardize for urine output.  DPD concentrations were not 
different due to treatment, but did differ by day of trial (P<0.05) with increased mean 
concentrations at d 128 (Table 10).   
 
 
 
Due to the large variation among the groups at d0, the data were normalized to d 
0 values.  The normalized data again showed no effect of treatment (Table 10).  At d 64, 
mean DPD concentrations in the low group appear to be higher than in the other three 
groups, yet due to the large variance in the data, the means were not statistically different 
(Figure 1).  Although other studies have successfully used DPD concentrations in horses 
to describe bone resorption, the extremely high individual variance precludes statistical 
confidence at traditional levels in this study.  DePriest et al. (1995) also reported high 
Table 10.  Mean urinary deoxypyridinoline crosslinks (DPD) in juvenile rachorses at varying mineral intakes
D0 D64 D128 D0 D64 D128
Low   37.77 151.18 135.10 0 128.77 112.69
  SEM   15.45   63.62   12.74   64.52   12.14
Moderate   61.06   94.26 178.22 0   33.20 117.16
  SEM   35.08   26.78   27.15   30.79   44.37
Moderate-High   97.36 103.74 204.42 0     6.39   87.54
  SEM   46.47   35.67   38.02   62.19   60.11
High 113.47   88.61 235.31 0  -24.86 104.85
  SEM   41.39   28.85   14.37    38.42    55.11
All Groups     79.13a  106.32a  187.67b 0   28.19 106.24
  SEM    18.44   18.06  14.63   25.67   21.30
a,bRow means not sharing superscripts differ (P<0.001)
∆ DPD
(nmol/mmol creatinine)
DPD
(nmol/mmol creatinine)
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day-to-day intra-individual variation in human subjects (between 10.7 and 15.5%) using 
an ELISA assay and over 25% using HPLC methods. 
 
 
 
Figure 1.  Mean change in urine DPD/creatinine concentrations in juvenile racehorses at 
varying mineral intakes. 
 
 
Serum ICTP 
 Serum ICTP concentrations were not different between treatment groups, but did 
differ significantly (P<0.001) by day of trial.  ICTP increased with the introduction of 
race training, from d 0 to d 14 (P<0.01), and remained elevated through d 60 (Figure 2; 
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Appendix 8).  Concentrations during the second half of the training period (d 71 through 
d 124) were lower than those seen during the first half, however, concentrations were 
still higher than d 0 values with the exception of two days (d 78, d 85).  At d 128, 4 days 
following the completion of training and the end of a 4-day total collection, ICTP 
concentrations were similar to pretrial values.  Particularly noteworthy was a significant 
drop (P<0.0001) in ICTP concentrations that was seen at d 64 following 4 days of 
confinement concurrent with total urine and fecal collections.  During the collection 
periods, horses were completely inactive for 96 hours with the exception of 1 hour per 
day when they were walked on a mechanical walker.  ICTP concentrations increased 
again by d 71 (P<0.05) following the return to training. 
When data were normalized, there was a significant effect of treatment as the low 
group had higher ICTP concentrations (P<0.05) on average than the moderate-high and 
high groups (Figure 3).  This was particularly pronounced at d 60 (although there was 
not a significant treatment by day interaction) and toward the end of the training period 
when ICTP concentrations in the moderate-high and high groups had returned to d 0 
values.  Further, regression analysis revealed a significant negative relationship (Figure 
4) between Ca intake and ICTP (P<0.005).  Calculated elasticities for the relationship 
between Ca and ICTP from d 32 to d 128 indicated that each 1 % increase in Ca in the 
diet (g/day) led to an 18.9% decrease in serum ICTP.  Serum ICTP intra-assay 
coefficient of variation (CV) was less than 5% and inter-assay CV was 5.7%. 
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Figure 2.  Mean serum ICTP concentration in juvenile racehorses by day of trial (all 
groups). 
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Figure 3.  Mean change in serum ICTP concentrations in juvenile racehorses at varying 
mineral intakes.  a,b,cGroups not sharing common superscripts differ (P<0.05). 
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 Figure 4.  Relationship between ICTP and Ca intake in juvenile racehorses in training. 
 
 
Serum PICP 
 Serum PICP was different by day of trial (P<0.001) with concentrations 
increasing significantly by 14 days into training and remaining elevated through d 110 
(Figure 5, Appendix 10).  By d 128 of training, concentrations were no longer different 
from d 0 values.  Similar to the ICTP data, precipitous decreases in PICP were seen 
following 4 days of confinement at d 64 (P=0.08) and d 128 (P<0.05).   
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Figure 5.  Mean serum PICP concentrations in juvenile racehorses by day of trial. 
 
 
Additionally, there was a significant effect of treatment on PICP concentrations 
(P<0.001) with horses in the moderate-high and high groups exhibiting significantly 
higher concentrations than the two lower mineral intake groups.  Horses in the low 
intake group exhibited the lowest concentrations with a trial average of 1,180.48 ng/mL, 
followed by the moderate group with a trial average of 1,382.08 ng/mL.  Average 
concentrations for the moderate-high and high groups were similar at 1,619.26 ng/mL 
and  1,589.99 ng/mL, respectively (Appendix 8B).  Regression analysis revealed a 
significant positive relationship (Figure 6) between Ca intake and PICP (P<0.001).  
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Calculated elasticities for the relationship between Ca and PICP from d 32 to d 128 
indicated that each 1 % increase in Ca in the diet (g/day) led to a 32% increase in serum 
PICP. 
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 Figure 6.  Relationship between PICP and Ca intake in juvenile racehorses in training. 
 
 
 When data were normalized, there was a similar effect of treatment (P<0.001) 
with the high intake group exhibiting significantly higher serum PICP than the low and 
moderate groups (P<0.05).  This was particularly pronounced from d 56 to d 64, 
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although there was not a significant treatment by day interaction (Figure 7).  Intra-assay 
CV for serum PICP was less than 5% and inter-assay CV was 3.9%. 
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Figure 7.  Mean change in serum PICP concentrations in juvenile racehorses at varying 
mineral intakes.  a,b,cGroups not sharing common superscripts differ (P<0.05). 
 
Plasma Osteocalcin 
 Osteocalcin concentrations differed by day of trial (Figure 8) with the same trend 
for decreased concentrations following total collections at d 0 (P<0.05) and d 64 (P=0.1).  
Although osteocalcin appeared to be somewhat elevated during training, values were not 
significantly different from baseline (d -4) at any time.  Additionally, osteocalcin was 
  
35
 
different by treatment (P<0.05), although the only difference was seen between the low 
and high intake group (Table 11).  When data were normalized in order to take out 
variation at baseline, there was no effect of treatment (Table 11).  Plasma osteocalcin 
intra-assay CV was less than 5% and inter-assay CV was 7.4%. 
 
 
 
Figure 8.  Mean plasma osteocalcin concentrations in juvenile racehorses by day of trial 
(all groups). 
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Table 11. Mean osteocalcin concentrations in juvenile racehorses at varying
mineral intakes
Low Moderate Mod-High High
Osteocalcin, ng/ml 10.45a   9.87a,b   9.79a,b  9.45b
  SEM 0.33 0.19 0.21 0.19
∆Osteocalcin, ng/ml 0.65 -0.16 0.43 0.50
  SEM 0.29  0.23 0.16 0.19
a,bColumn means not sharing common superscripts differ (P<0.05)  
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CHAPTER V 
DISCUSSION 
 
 Two complications with the study lead to reorganization of the animals from the 
predetermined diet treatment groups into groupings of animals based on their actual Ca 
intake.  The first problem occurred with a suspected manufacturing inconsistency, in 
which the concentrates did not contain the formulated amounts of Ca, P and Mg 
specified in the research protocol.  Second, feeding the horses to maintain a constant 
body condition during training instead of feeding to a percentage of body weight created 
an additional complication.  Horses on the designated “low” feed were, in some cases, 
actually taking in more mineral than horses consuming a feed with higher mineral 
concentration.   Reorganization of the horses into groups reflecting actual mineral intake 
per kg of body weight provided the opportunity to better evaluate the effects of varying 
mineral concentrations in the diet.   
 
Exercise Effects 
Exercising untrained horses at high speeds, such as in race training, increases 
both strain magnitude and strain rate thereby initiating skeletal adaptations. 
In the present study, concentrations of ICTP and PICP increased significantly from 
baseline values with the onset of race training and remained elevated through the 
majority of the training period.  The fact that both markers followed similar patterns 
indicates that resorption and formation in theses horses were coupled.  Julen-Day et al. 
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(1997) also reported an increase in bone activity with exercise.  Within just 14 days of 
training under saddle, osteocalcin concentrations increased significantly in 2-year-old 
horses.  Other studies have not reported the same dramatic increase in bone markers with 
the introduction of exercise.  In a study by Price et al. (1995b) of 2-year-old horses, 
PICP and ICTP decreased throughout the trial in both a control group and a group 
exercised 3 days per week on a high-speed treadmill.  Although the authors attributed 
this to the normal age related decrease seen in bone markers, ICTP and PICP 
concentrations were significantly higher in the exercised horses.  Age of the horses and 
intensity of the exercise program were two major differences between the study 
conducted by Price et al. (1995b) and the present study, and most likely contributed to 
the differences in the pattern of bone markers in the exercised animals.  This age related 
decrease seen in biochemical markers has been shown in numerous studies.  Lepage et 
al. (1990) reported a significant negative correlation between osteocalcin and age when 
comparing horses between birth and 20 years of age, indicating a slowing of the rate of 
bone formation in adults.  Further, in a study by Price et al. (1995a), concentrations of 
bone markers such as bone specific alkaline phosphatase (BALP), ICTP and PICP 
decreased as horses aged, with the greatest changes occurring during the first 2 years.   
As compared to the present study, a study by Hiney et al. (2000) of racehorses of 
a similar age put into a similar training protocol did not show increases in biochemical 
markers as quickly during the onset of race training, although ICTP did gradually 
increase throughout the trial.  The reason for the discrepancy between these two studies 
is unclear since the age of the horses and the intensity of training was similar.  However, 
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the horses in the study conducted by Hiney et al. were preconditioned for 14 weeks on a 
high-speed treadmill prior to initiation of training on the track.  Additionally, even in a 
similar training protocol it is difficult to standardize speed and effort between horses; an 
issue compounded by different exercise riders.  Design of the exercise program can 
result in differences in the way the bone remodels.  In a study by Sherman et al. (1995) 
longer duration of training resulted in greater cortical area and dorsopalmer third 
metacarpal bone diameter in bone taken from 2, 3 and 4-year-old Thoroughbreds.  
Additionally, peak principle strain as well as peak strain rate increases linearly with 
increasing speed in the horse (Davies et al., 1993).  Therefore, it is likely that the 
differences in exercise intensity between the present study and the study conducted by 
Hiney et al. (2000) accounted for the differences seen in the pattern of change in bone 
markers.   
Higher concentrations of ICTP (bone resorption marker) during the first half of 
the training protocol in this study seem to agree with the decrease in bone density seen in 
other studies.  In a study of long-yearlings in race training, Neilsen et al. (1997) reported 
decreased bone density at d 62 of training followed by a subsequent increase out to  
d 244.  Decreased density of the lateral cortex was also seen at d 42 and d 56 of race 
training in 2-year-old horses (Julen-Day et al., 1997).   
It is unclear why osteocalcin concentrations did not increase significantly due to 
introduction of exercise as did ICTP and PICP.  Other studies have successfully used 
osteocalcin concentrations in horses to describe changes in bone activity due to age, and 
in response to exercise.  The radioimmunoassay technique used in this study has been 
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used in other studies involving horses (Julen-Day et al., 1997; Black et al., 1999; Lepage 
et al., 1998; Hiney et al., 2000) and coefficients of variation in this study were low.  
However, degradation of osteocalcin molecules occurs within a few hours if serum is left 
at room temperature before being frozen.  The assay used in this study employs 
polyclonal antibodies raised against bovine osteocalcin.  The bovine RIA does not 
recognize the N-terminal midpeptide fragment of osteocalcin which may affect the 
sensitivity of the assay to detect significant changes (Garnero and Delmas, 1996).  Blood 
samples in this study were placed on ice following collection, serum was separated by 
refrigerated centrifugation within 4 hours, and samples were immediately frozen.  
Although care was taken in handling of the samples it is possible that fragmentation of 
the intact osteocalcin molecule occurred causing lowered sensitivity of the assay.  
As was mentioned earlier, DPD was disappointing in its effectiveness to monitor 
changes in bone resorption due to the high variance in the data.  The method used for 
determination of DPD concentrations in this study was different than methods used in 
previous studies.  The chemiluminescent enzyme immunoassay employed here was 
developed for use with the IMMULITE Automated Analyzer.  This assay uses the same 
monoclonal antibody as an enzyme-linked immunosorbent assay from MetraBiosystems, 
Inc.  While data from the company indicates that the two assays are equally valid, this 
may not be true.  Similar problems with this particular assay have been reported in 
another study (Hiney, 1999).  In addition, data from other studies involving horses have 
failed to show an effect of exercise on DPD.  In a study by Hoekstra et al. (1999) 
initiation of exercise did not produce significant changes in DPD concentrations in 
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horses that were either confined or left on pasture.  Black et al. (1997) also saw no 
change in DPD concentrations in Standardbreds subjected to a moderate exercise 
program. It must also be taken into consideration that DPD concentrations were analyzed 
in urine taken during confinement periods only.  Given the data obtained from the other 
bone markers, it is possible that DPD concentrations might somehow be effected by 
inactivity of the animal thereby further complicating interpretation. 
 
Effects of Confinement  
Several studies have shown that disuse or reduction in physical activity causes a 
reduction in bone mass in many species (Merchant and Broom, 1986; Iwamoto et al., 
2000; Bell et al., 2001).  Stall confinement caused a decrease in bone density in yearling 
horses that remained low even after 56 d of conditioning (Hoekstra et al., 1999).  Of 
particular interest in this study were the dramatic decreases seen in osteocalcin, PICP 
and ICTP following just 4 days of confinement and relative inactivity.  Although not as 
dramatic, a similar decrease in bone markers was observed by Hiney et al. (2000).  
Osteocalcin, ICTP and PICP decreased in long-yearlings after 2 days of stall 
confinement following 14 weeks of treadmill training.  Similarly, Nielsen et al. posited 
this effect after a pair of studies where decreased confinement periods of young horses 
resulted in less dramatic increases in bone remodeling (Neilson et al 1998, 1997).  As the 
change in all serum markers in these studies were similar following confinement, it 
seems as though the juvenile equine skeleton responds to inactivity with an overall 
decrease in total bone activity.  Human studies have documented significant increases in 
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bone resorption markers after just a few days of bed rest (Lueken et al., 1993).  A study 
by Pedersen et al. (1995) reported a decrease in PICP concentrations and an increase in 
osteocalcin after just 3 days of bed rest in humans.  These studies indicate that bone is 
sensitive to daily changes in physical activity and responds quickly to differences in 
strain.  Further, blood-borne biochemical markers are sensitive enough to track daily 
changes in bone activity.   
 
Diet Effects 
 In this study, Ca intake ranged from 97 to 170% of NRC (1989) 
recommendations.  Horses in the low mineral intake group experienced greater bone 
resorption, as measured by ICTP, than horses in the two highest intake groups.  
Additionally, greater bone formation, as measured by PICP, was seen in horses in the 
high mineral intake group when compared to horses in the two lowest intake groups.  
Osteocalcin showed no differences due to mineral intake most likely for the reasons 
mentioned earlier.  Given that bone formation and resorption were coupled, osteocalcin 
is probably best interpreted as indicative of total bone activity.  Therefore greater 
amounts of bone formation coupled with lesser amounts of bone resorption in the high 
group would result in the same amount of total bone activity as horses experiencing the 
opposite.  In agreement with these findings, Neilsen et al. (1998) evaluated Ca retention 
and bone mineral content in a group of young horses in race training fed a diet 
containing either 0.38% or 0.31% Ca.  Greater Ca retention along with greater mineral 
content of the third metacarpus was reported in horses fed the high Ca diet.  In a study of 
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mature horses introduced to exercise on a treadmill, increase in bone mineral content in 
response to training only occurred in horses fed diets containing 0.69% Ca, and greater 
increases in osteocalcin were observed in horses fed 0.69% Ca than in horses fed 0.35% 
Ca (Porr et al., 2000).  In contrast, Schryver et al. (1978) reported no benefit in feeding a 
diet containing 0.6% Ca versus a diet containing 0.4% Ca to young Standardbreds put 
into training.   
When evaluating the results of mineral intake, it is important to consider whether 
the requirements were based on a percentage basis in the diet, or as grams needed per 
day.  It may often be assumed that as feed intake increases to meet the demands for 
energy associated with increased work, any additional mineral requirements will also be 
met.  This would be expected when mineral concentrations are sufficient relative to 
energy and horses actually receive enough energy to support work.  However, in young, 
exercising horses this is not necessarily the case.  In the study conducted by Neilsen et 
al. (1998), when total Ca intake was considered, the control diet provided only 80 to 
85% of NRC (1989) recommendations and the high mineral diet provided approximately 
100% of recommendations.  When examined from this perspective, it may not be 
appropriate to infer suitability of NRC recommendations based on studies where total 
daily intake is not evaluated.  In the present study, treatment groups were based on 
absolute mineral intake.  These data suggest that feeding Ca and other minerals at 
intakes greater than current NRC recommendations may have a protective effect on the 
bone.  Calcium is directly associated with bone through its incorporation into 
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hydroxyapatite and removal of Ca from bone to meet metabolic demands during dietary 
Ca deficiency can result in a weakened skeleton. 
Increased ICTP concentrations early in the training season have been correlated 
to development of dorsal metacarpal disease (DMD) (Jackson et al., 2005).  Further, 
young horses with greater cortical mass in the lateral, medial and dorsal aspects of the 
third metacarpal in relation to the palmer aspect experienced fewer bone injuries during 
race training (Neilsen et al., 1997).  Greater amounts of bone formation coupled with 
lesser bone resorption, as was seen in the high and moderate-high intake groups in the 
present study, would likely result in greater mineral density and therefore greater 
strength.   
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 Of all the factors influencing the skeletal architecture in growing horses, physical 
activity is probably the most important.  Stimulating the skeleton to remodel early on can 
better prepare these animals to withstand the intensity of racing.  However, at some 
point, the beneficial effects of exercise are lost and bone failure can occur.  Therefore the 
goal of any training program should be to adequately strengthen the skeleton while 
avoiding overtraining that can result in injury.  Certainly the challenge of the racing 
industry is to reduce the number of injuries to young horses through the development of 
better training and management techniques, and possibly by monitoring the state of 
bone, particularly through the initial stages of training.  Fatigue strain of immature bone 
is the primary cause of dorsal metacarpal disease, which leads to delays in training and 
loss of opportunity for competition.  It has also been suggested that an additional cause 
of dorsal metacarpal disease is the repair process itself.  The remodeling process causes 
an increase in the porosity of the bone during the resorption phase resulting in weakened 
bone.  It has been proposed that the introduction of speed work in the majority of typical 
race training programs occurs at the point when the bone is at its weakest.   
 An additional challenge in management of skeletal development in these athletes 
is proper nutrition.  As bone formation increases in response to exercise, so does the 
need for additional Ca and other minerals, but to what extent, researchers are still unsure.  
Even in humans there are incomplete data on how Ca requirements are modified due to 
different amounts of physical activity (Weaver, 2000).   
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 The data presented here indicate that bone activity increases due to the 
introduction of race training in long-yearling horses.  Further, since formation and 
resorption were coupled, it is likely that these horses were undergoing bone remodeling 
specifically rather than just bone modeling.  Additionally, concentrations of the bone 
resorption marker were highest during the first 60 days of training which agrees with 
other studies that have reported decreased bone mineral density from around day 42 to 
day 60 of training.  The traditional method of training young racehorses may actually be 
the most direct cause of injury as the bone is not being properly prepared.  In most 
training programs, horses are conditioned at slow speeds for extended periods.  Thus the 
bone has remodeled for the strains associated with long, slow, distance work and is 
unprepared for the loads associated with speed work.  In traditional training programs, it 
is typically when speed work is introduced that problems arise.  A suggested alternative 
is the introduction of short sprints early in training in order to induce changes that would 
prepare the bone for racing speeds.  Hence, the bone adapts early on to the stress it will 
ultimately undergo without introducing the high strain, cyclic fatigue associated with 
long bouts of speed.   
Of particular interest was the precipitous drop that occurred in ICTP, PICP and 
osteocalcin after just 4 days of the horses being placed in confinement.  These data are in 
agreement with studies in humans that have documented significant responses of bone 
markers within days of introduction of bed rest.  This reveals not only that bone 
responds rather quickly to daily changes in the amount of load upon it, but that some of 
these biochemical markers are sensitive enough to pick up daily changes in the resulting 
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bone activity.  This dramatic response to inactivity helps to further support the idea that 
long periods of stall confinement can result in a negative outcome on the bone.  In this 
study, skeletal disuse due to confinement triggered at least as much response as 
increased loading.  Management practices of yearlings prior to training are often not 
considered by trainers to have any impact on the animal’s career.  Yearlings are typically 
confined to stalls in preparation for sales and at the conclusion of the fall sales, the 
horses will usually be placed immediately into a training program.  The data presented 
here and in other studies indicates that the response of the skeleton to confinement is 
both rapid and dramatic.  Thus many of these animals are beginning training with 
already weakened bone.   
In addition to changes that were noted due to exercise, differences in bone 
marker concentrations were observed among the groups.  Horses consuming lower 
amounts of Ca, P and Mg had significantly higher concentrations of the bone resorption 
marker which has been linked to greater risk for development of DMD.  Higher mineral 
intakes resulted in greater amounts of bone formation coupled with lesser amounts of 
bone resorption suggesting a protective effect of these minerals on bone.  Reducing the 
amount of bone resorption taking place should decrease porosity of the bone, thereby 
increasing its resistance to damage.  Therefore, feeding Ca, P and Mg at levels above 
NRC (1989) recommendations appears to provide a protective effect on the bone during 
race training. Consequently current recommendations may not be sufficient to maximize 
bone strength.  However, it is not possible to make any kind of specific 
recommendations based on these data alone.  The effect of any one mineral was 
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confounded by varying levels of the other two minerals, particularly in regards to P and 
Mg.  It would certainly be beneficial to study the individual effects each of these 
minerals may have on bone activity in young race horses.   
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APPENDICES 
 
1.  INGREDIENT COMPOSITION OF THE CONCENTRATESa 
 
 
 
 
 
 
 
 
Ingredient Diet A Diet B Diet C Diet Db
Corn 79.27 64.57 59.63 31.61
Oats - 10.1 10 10
Soybean Meal 1 13.5 15 7.5
Wheat Middlings - - 3.8 39.79
Corn Gluten Meal 10.85 1.3 - -
Yeast Culture 0.5 0.5 0.5 0.5
Calcium Carbonate 0.91 0.95 1.38 1.67
Monocalcium Phosphate - - 0.55 -
Salt 0.77 0.77 0.77 0.77
Magnesium Oxide - - 0.11 -
Potassium Chloride 0.21 - - -
Selenium 0.06% 0.05 0.05 0.05 0.05
Lysine 0.49 0.11 0.06 0.16
Flavoring 0.15 0.15 0.15 0.15
Trace Mineral Premix 0.1 0.1 0.1 0.1
Vitamin Premix 0.05 0.05 0.05 0.05
Fat 2 2.2 2.2 2
Molasses 3 5 5 5
Calcium Propionate 0.15 0.15 0.15 0.15
Binder 0.5 0.5 0.5 0.5
aFormulation provided by Consolidated Nutrition, Inc., Omaha, Nebraska
bPatriot 14-P, Consolidated Nutrition, Inc.
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2.  CALCIUM, PHOSPHORUS AND MAGNESIUM INTAKE 
 
 
 
Total Ca Int Total P Int Total Mg Int
Horse Day Diet Group (mg/kg BW/d) (mg/kg BW/d) (mg/kg BW/d)
1A 0 A Low 111.54 43.21 30.04
2A 0 A Low 144.06 55.34 38.04
6A 0 A Low 111.07 42.22 28.06
1C 0 C Low 103.16 39.19 26.53
2C 0 C Low 72.02 27.86 19.34
5A 0 A Moderate 180.17 68.32 46.15
1B 0 B Moderate 128.80 49.56 34.15
3B 0 B Moderate 144.79 55.03 37.29
5C 0 C Moderate 107.57 40.8 27.56
1D 0 D Moderate 145.40 55.59 37.98
3C 0 C Moderate-High 143.73 54.68 37.09
2D 0 D Moderate-High 165.74 63 42.7
4D 0 D Moderate-High 162.28 61.7 41.82
6D 0 D Moderate-High 138.49 52.42 35.32
4B 0 B High 144.11 54.79 37.14
6B 0 B High 139.34 52.85 35.71
4C 0 C High 169.68 64.54 43.78
6C 0 C High 115.99 44.2 30.05
5D 0 D High 138.11 52.33 35.31
1A 64 A Low 66.33 21.97 15.44
2A 64 A Low 89.99 27.4 17.89
6A 64 A Low 80.46 24.43 15.9
1C 64 C Low 106.37 37.22 25.96
2C 64 C Low 94.75 33.31 23.38
5A 64 A Moderate 117.45 36.19 23.93
1B 64 B Moderate 125.28 40.66 26.13
3B 64 B Moderate 123.55 40.11 25.8
5C 64 C Moderate 124.32 43.41 30.21
1D 64 D Moderate 121.32 51.12 35.4
3C 64 C Moderate-High 139.34 48.72 33.96
2D 64 D Moderate-High 139.60 58.91 40.25
4D 64 D Moderate-High 128.18 54.07 37.06
6D 64 D Moderate-High 137.80 58.13 39.88
4B 64 B High 159.49 52.82 34.9
6B 64 B High 152.49 49.35 31.6
4C 64 C High 166.22 58.13 40.53
6C 64 C High 141.15 49.34 34.38
5D 64 D High 146.53 61.84 42.23
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Total Ca Int Total P Int Total Mg Int
Horse Day Diet Group (mg/kg BW/d) (mg/kg BW/d) (mg/kg BW/d)
1A 128 A Low 101.64 31.08 20.82
2A 128 A Low 107.28 31.45 21.12
6A 128 A Low 86.88 25.33 17.02
1C 128 C Low 145.25 47.5 35.41
2C 128 C Low 112.50 36.53 27.29
5A 128 A Moderate 124.77 35.79 24.06
1B 128 B Moderate 127.66 55.54 27.03
3B 128 B Moderate 128.23 55.58 26.85
5C 128 C Moderate 117.96 38.15 28.54
1D 128 D Moderate 135.34 55.72 39.22
3C 128 C Moderate-High 133.90 43.77 32.64
2D 128 D Moderate-High 146.82 60.24 42.45
4D 128 D Moderate-High 82.74 35.66 24.74
6D 128 D Moderate-High 120.40 49.65 34.93
4B 128 B High 138.30 59.86 28.84
6B 128 B High 134.17 57.83 27.63
4C 128 C High 139.32 45.73 34.05
6C 128 C High 133.24 43.28 32.33
5D 128 D High 125.40 51.38 36.22
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3.  PHYSICAL MEASUREMENTS OF HORSES 
Weight Hip Height Whither Height Body Length Heartgirth Rump Fat
Horse Diet Group Day (kg) (cm) (cm) (cm) (cm) (mm2)
1A A L 0 365.47 149.23 146.05 156.85 164.78 8
1C C L 0 467.62 159.39 153.04 173.67 176.53 4
2A A L 0 343.68 147.96 140.34 156.21 164.78 3
2C C L 0 424.49 151.13 145.42 169.23 176.53 4
6A A L 0 352.76 145.42 139.70 157.48 163.83 3
1B B M 0 421.77 154.94 147.96 170.82 170.82 6
1D D M 0 344.13 149.86 146.05 155.58 168.91 3
3B B M 0 422.22 154.94 149.23 162.88 175.26 4.5
5A A M 0 339.14 152.40 147.96 157.48 167.32 1
5C C M 0 407.24 152.40 149.23 162.56 170.18 5
2D D MH 0 360.48 151.13 145.42 165.74 163.20 3.5
3C C MH 0 340.50 149.23 144.15 160.34 164.78 5.5
4D D MH 0 429.03 155.58 148.59 178.44 173.99 4.5
5B B MH 0 384.54 156.21 152.40 161.93 172.72 2.5
6D D MH 0 400.43 154.94 151.13 166.37 147.00 2
3D D H 0 347.31 151.13 146.69 159.39 165.10 5
4B B H 0 410.42 158.75 153.04 167.96 177.80 6
4C C H 0 356.39 154.94 150.50 165.10 168.59 4
5D D H 0 370.92 149.86 145.42 160.02 168.28 2.5
6B B H 0 365.92 152.40 150.50 158.75 170.82 2
6C C H 0 361.84 150.50 146.05 158.75 170.18 2
1A A L 64 371.83 152.40 149.86 161.29 168.59 4.5
1C C L 64 458.54 161.29 156.85 173.99 179.07 5
2A A L 64 354.12 149.86 145.42 157.48 162.24 2.5
2C C L 64 437.66 151.77 147.32 168.91 173.99 5
6A A L 64 376.82 147.96 142.24 159.39 166.37 4
1B B M 64 456.27 155.58 153.67 171.45 176.53 4.5
1D D M 64 363.20 152.40 148.59 157.48 168.91 3
3B B M 64 443.56 157.48 151.77 169.55 177.80 4
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Weight Hip Height Whither Height Body Length Heartgirth Rump Fat
Horse Diet Group Day (kg) (cm) (cm) (cm) (cm) (mm2)
5A A M 64 365.02 153.04 150.50 155.26 168.91 1.5
5C C M 64 424.94 153.67 151.13 159.39 172.72 4
2D D MH 64 379.54 - - - - -
3C C MH 64 363.65 175.90 146.69 163.20 167.96 2.5
4D D MH 64 444.01 159.39 153.04 177.80 175.90 4.5
5B B MH 64 417.23 158.12 156.21 163.51 176.21 3
6D D MH 64 427.21 154.94 153.04 165.10 176.53 3
3D D H 64 384.54 152.40 149.23 163.83 170.18 3
4B B H 64 440.38 156.21 152.40 167.64 179.07 8
4C C H 64 398.61 156.85 153.67 154.94 173.99 4
5D D H 64 381.36 151.13 147.32 153.67 169.55 3
6B B H 64 400.43 154.31 153.04 163.20 176.53 4
6C C H 64 381.81 152.40 149.86 154.31 174.63 2.5
1A A L 128 376.82 153.67 151.13 167.64 167.64 3
1C C L 128 491.23 160.02 156.21 175.26 179.07 3.5
2A A L 128 395.43 150.50 147.32 160.02 167.64 4
2C C L 128 472.16 150.50 146.69 173.99 175.26 4
6A A L 128 405.88 148.59 143.51 169.23 172.09 5
1B B M 128 467.62 155.58 153.67 174.63 176.53 4
1D D M 128 397.25 151.77 149.23 161.29 170.18 4
3B B M 128 465.35 158.75 154.31 173.04 178.44 3
5A A M 128 411.78 154.94 150.50 163.83 175.26 5
5C C M 128 451.28 154.94 152.40 167.64 173.36 7
2D D MH 128 412.23 154.31 153.67 165.74 168.91 7
3C C MH 128 400.43 150.50 149.23 167.01 171.45 2.75
4D D MH 128 476.25 159.39 155.58 182.88 177.80 3
5B B MH 128 471.25 160.02 157.48 167.64 181.61 3.5
6D D MH 128 458.09 153.67 153.67 164.47 177.80 3
3D D H 128 419.50 153.04 147.96 168.91 175.90 3.5
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Weight Hip Height Whither Height Body Length Heartgirth Rump Fat
Horse Diet Group Day (kg) (cm) (cm) (cm) (cm) (mm2)
4B B H 128 460.81 158.12 154.94 167.01 179.71 9
4C C H 128 438.56 156.85 154.94 166.37 176.85 5
5D D H 128 407.69 151.13 147.96 162.56 172.09 3
6B B H 128 444.92 155.58 154.94 167.64 180.34 4.5
6C C H 128 432.66 153.04 151.77 158.75 176.53 4
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4.  DPD CONCENTRATIONS FOR ALL HORSES 
 
 
 
DPD Creatinine DPD/Creatinine
Horse Diet Group Day (nmol/day) (µmol/day) (nmol/mmol)
1A A L 0 720.791 33536.53 21.493
1A A L 64 1021.52 3657.63 279.285
1A A L 128 944.748 5944.39 158.931
2A A L 0 709.562 24517.5 28.941
2A A L 64 890.078 22277.2 39.955
2A A L 128 591.874 4539.81 130.374
5A A M 0 1204.158 50863.41 23.674
5A A M 64 1068.547 21743.94 49.142
5A A M 128 1284.088 5014.93 256.053
6A A L 0 927.725 9352.59 99.194
6A A L 64 - - -
6A A L 128 - - -
1B B M 0 1016.544 19863.46 51.177
1B B M 64 1184.24 15284.29 77.481
1B B M 128 1316.869 5911.85 222.751
3B B M 0 1037.151 78780.61 13.165
3B B M 64 982.768 6198.79 158.542
3B B M 128 1064.385 7738.91 137.537
4B B H 0 821.063 46485.37 17.663
4B B H 64 828.734 40987.85 20.219
4B B H 128 1334.438 6189.93 215.582
5B B MH 0 1287.12 8932.75 144.09
5B B MH 64 1422.988 76197.63 18.675
5B B MH 128 993.6 7972.03 124.636
6B B H 0 817.976 6019.3 135.892
6B B H 64 1305.175 20342.8 64.159
6B B H 128 - - -
1C C L 0 801.158 39487.93 20.289
1C C L 64 1268.881 5246.05 241.874
1C C L 128 1284.894 12683.14 101.307
2C C L 0 879.7 46510.94 18.914
2C C L 64 1494.728 34281.17 43.602
2C C L 128 766.688 5118.86 149.777
3C C MH 0 767.97 18585.25 41.321
3C C MH 64 1304.741 10773.68 121.105
3C C MH 128 1431.795 5143.25 278.383
4C C H 0 1012.42 43893.76 23.065
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DPD Creatinine DPD/Creatinine
Horse Diet Group Day (nmol/day) (µmol/day) (nmol/mmol)
4C C H 64 1338.343 11432.65 117.063
4C C H 128 - - -
5C C M 0 1126.569 5662.83 198.941
5C C M 64 1178.76 7559.96 155.921
5C C M 128 1366.25 8198.16 166.653
6C C H 0 917.993 4327.23 212.144
6C C H 64 1164.41 33085.61 35.194
6C C H 128 1321.172 6301.1 209.673
1D D M 0 888.633 48416.8 18.354
1D D M 64 612.203 20261.47 30.215
1D D M 128 550.938 5096.81 108.095
2D D MH 0 939.004 48749.29 19.262
2D D MH 64 1281.044 5950.03 215.3
2D D MH 128 - - -
3D D H 0 1020.662 24354.56 41.908
3D D H 64 805.838 10062.51 80.083
3D D H 128 1290.066 5291.89 243.782
4D D MH 0 1242.45 54383.11 22.846
4D D MH 64 1411.235 41064.36 34.366
4D D MH 128 - - 154.903
5D D H 0 798.244 3191.43 250.121
5D D H 64 921.384 4286.61 214.945
5D D H 128 1370.925 5036.54 272.196
6D D MH 0 1341.251 5173.31 259.263
6D D MH 64 1080.095 8355.54 129.267
6D D MH 128 1406.681 5415.46 259.753
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5.  ANOVA TABLE FOR DEOXYPYRIDINOLINE 
 
 
 
 
 
 
 
 
 
Source df SS MS F-value P-value
DPD
  Model 11 167.977.144 15270.649 2.57 0.0126
  Group 3 14656.179 4885.393 0.82 0.4892
  Day 2 118456.915 59228.457 9.95 0.0003
  Group *Day 6 37523.553 6253.925 1.05 0.4058
  Error 46 273851.373 5953.291
  Total 57 441828.516 7751.377
Normalized DPD
  Model 11 172955.628 15723.239 2.32 0.0231
  Group 3 24301.6714 8100.557 1.20 0.3222
  Day 2 105488.982 52744.491 7.78 0.0012
  Group *Day 6 38451.027 6408.504 0.95 0.4723
  Error 46 311812.740 6778.538
  Total 57 484768.368 8504.708
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6.  ICTP, PICP AND OSTEOCALCIN CONCENTRATIONS 
 
 
Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
1A A L -4 948.1 8.4 9.3624
1A A L 0 749.7 8.63 9.15
1A A L 14 1181.25 12.15 8.8538
1A A L 28 1222.35 12.7 10.562
1A A L 32 1417.7 14.64 12.416
1A A L 39 1483.05 11.76 9.9598
1A A L 46 1404.7 14.542 14.178
1A A L 53 1489.15 12.7 12.192
1A A L 60 1010.45 17.082 12.275
1A A L 64 760.9 10.73 8.0281
1A A L 71 748.55 12.73 8.3986
1A A L 78 875.55 9.87 9.527
1A A L 85 1218.35 12.94 12.206
1A A L 92 1410.45 16.03 11.464
1A A L 96 1355.25 15.14 -
1A A L 110 1796.95 13.48 15.072
1A A L 124 1543.2 14.66 13.373
1A A L 128 970.5 13.76 12.098
2A A L -4 1059.4 9.1 9.8575
2A A L 0 1522.75 9.48 10.799
2A A L 14 1503.65 11.94 12.247
2A A L 28 1665.55 11.92 11.809
2A A L 32 1645.75 14.65 12.208
2A A L 39 668.95 10.63 6.751
2A A L 46 1256.7 12.914 11.065
2A A L 53 1165.9 13.601 -
2A A L 60 - - -
2A A L 64 - - -
2A A L 71 - - -
2A A L 78 - - -
2A A L 85 - - -
2A A L 92 - - -
2A A L 96 - - -
2A A L 110 - - -
2A A L 124 - - -
2A A L 128 - - -
5A A M -4 1166.9 13.84 10.433
5A A M 0 1140.5 15.79 6.0325
5A A M 14 858.4 19.251 5.5364
5A A M 28 1053.95 16.58 10.974
5A A M 32 818.65 14.45 9.009
5A A M 39 1407.15 17.49 11.228
5A A M 46 1692.15 17.51 11.823
5A A M 53 1317.55 16.572 -
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
5A A M 60 1582.35 14.22 9.9799
5A A M 64 1068.05 11.26 9.9282
5A A M 71 - - -
5A A M 78 - - -
5A A M 85 1635.1 13.06 11.294
5A A M 92 1381.25 18.15 15.352
5A A M 96 1870.6 19.59 12.223
5A A M 110 1044.35 16.1 11.863
5A A M 124 1652.3 17.018 10.55
5A A M 128 1043.55 13.59 8.8229
6A A L -4 1134.05 11.2 13.116
6A A L 0 766.8 9.98 10.978
6A A L 14 1491.7 14.47 -
6A A L 28 1585.55 19.06 14.91
6A A L 32 1623.95 19.31 14.413
6A A L 39 1682.6 20.93 14.728
6A A L 46 1257.4 15.97 12.908
6A A L 53 1563 20.47 14.117
6A A L 60 1518.4 19.506 14.429
6A A L 64 1246.8 17.17 15.074
6A A L 71 1731.25 18.06 15.525
6A A L 78 1723.7 16.07 14.611
6A A L 85 1080.15 13.19 12.45
6A A L 92 1148.8 16.97 15.175
6A A L 96 951.95 16.19 10.957
6A A L 110 1745.05 18.963 10.984
6A A L 124 910.35 13.81 9.8432
6A A L 128 716.8 16.228 9.4267
1B B M -4 1935.75 9.46 8.6404
1B B M 0 1251.35 10.997 8.7702
1B B M 14 1488.45 11.51 7.7513
1B B M 28 1570.05 13.82 8.4064
1B B M 32 1419.55 11.57 9.0132
1B B M 39 1503.45 11.51 7.9875
1B B M 46 1937.6 11.89 8.8647
1B B M 53 2026.05 12.562 7.1348
1B B M 60 1608.15 12.55 9.5338
1B B M 64 1571.75 8.22 7.4246
1B B M 71 1623.6 11.81 9.603
1B B M 78 1917.8 9.8 7.8305
1B B M 85 1061.9 9.28 8.2201
1B B M 92 1557.4 10.524 8.3317
1B B M 96 1368.55 12.34 9.1503
1B B M 110 1582.85 11.93 8.6191
1B B M 124 1565.1 13.106 8.2371
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
1B B M 128 1353.35 13.76 9.2157
3B B M -4 1268.55 10.1
3B B M 0 1390.8 12.359 8.4577
3B B M 14 1261.05 14.34 10.383
3B B M 28 1951.75 13.18 11.422
3B B M 32 1870 15.365 11.33
3B B M 39 1513.45 14.46 10.119
3B B M 46 1036.05 14.62 10.856
3B B M 53 1586.4 16.58 10.105
3B B M 60 1731.7 13.69 11.757
3B B M 64 1628.35 12.86 10.474
3B B M 71 1801.9 13.9 11.67
3B B M 78 1409.9 14.267 12.708
3B B M 85 1392.5 9.52 11.186
3B B M 92 1585.05 11.3 13.32
3B B M 96 1548.2 13.57 11.165
3B B M 110 1105.4 10.98 11.025
3B B M 124 1423.55 15.07 10.494
3B B M 128 1065.6 12.05 8.9471
4B B H -4 1055.95 12.385 8.0253
4B B H 0 923.65 10.029 7.9605
4B B H 14 1063.8 11.77 8.8415
4B B H 28 1611.3 12.79 10.543
4B B H 32 1684.75 12.72 8.8269
4B B H 39 1550.75 11.39 8.9416
4B B H 46 991.75 12.18 8.3944
4B B H 53 - - -
4B B H 60 1725.55 14.33 7.2255
4B B H 64 1418.35 10.26 8.8828
4B B H 71 1455.15 11.63 6.803
4B B H 78 1328.35 14.712 8.2876
4B B H 85 1089.6 11.74 7.0539
4B B H 92 1094.45 13.27 6.6187
4B B H 96 1200.75 11.05 7.9896
4B B H 110 1187.45 13.383 7.3531
4B B H 124 1443.5 12.27 7.4726
4B B H 128 906.85 13.91 5.977
5B B MH -4 1322.05 14 9.6779
5B B MH 0 - - -
5B B MH 14 - - -
5B B MH 28 1535.2 10.74 8.2672
5B B MH 32 1664.2 14.85 9.5537
5B B MH 39 1946.05 18.68 -
5B B MH 46 1484.5 20.827 7.6671
5B B MH 53 - - -
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
5B B MH 60 - - -
5B B MH 64 - - -
5B B MH 71 - - -
5B B MH 78 - - -
5B B MH 85 - - -
5B B MH 92 - - -
5B B MH 96 - - -
5B B MH 110 1820.1 14.97 8.7615
5B B MH 124 - - -
5B B MH 128 - - -
6B B H -4 1108.1 9.41 6.9841
6B B H 0 689.4 12.143 6.0363
6B B H 14 1407.45 10.92 8.4965
6B B H 28 1649.2 14.31 8.7801
6B B H 32 880.5 16.646 7.4572
6B B H 39 1753.05 17.12 9.5313
6B B H 46 1114.6 13.206 6.6256
6B B H 53 2368.75 14.21 9.8199
6B B H 60 2034 13.45 -
6B B H 64 1975.75 12.11 9.4038
6B B H 71 1665.45 16.26 8.5143
6B B H 78 2072.2 13.57 8.993
6B B H 85 1876.8 8.9 8.1219
6B B H 92 1627.2 14.57 8.5033
6B B H 96 1582.6 13.48 9.1132
6B B H 110 1823.9 13.35 9.5385
6B B H 124 1756.65 13.179 8.2401
6B B H 128 1451.55 11.98 7.8697
1C C L -4 1057.8 9.29 -
1C C L 0 720.6 10.44 9.4446
1C C L 14 803.5 10.51 9.6348
1C C L 28 1446.6 12.459 10.862
1C C L 32 1466.65 14.8 9.7866
1C C L 39 960.45 11.413 8.8596
1C C L 46 1315.7 11.3 10.002
1C C L 53 1328.6 11.843 9.4277
1C C L 60 553.6 13.03 8.271
1C C L 64 904.7 10.611 9.1627
1C C L 71 1605.8 9.95 9.5543
1C C L 78 1696.7 11.176 10.351
1C C L 85 851.85 10.63 7.8038
1C C L 92 1261.6 10.39 10.564
1C C L 96 1234.85 14.11 10.918
1C C L 110 952.05 12.17 9.4466
1C C L 124 938.7 10.19 8.5406
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
1C C L 128 636.3 11.62 7.9868
2C C L -4 964.45 11.34 6.9002
2C C L 0 516.75 8.5006 4.7701
2C C L 14 1136.3 14.71 7.591
2C C L 28 1031.45 13.61 6.4705
2C C L 32 1114.1 14.92 8.1903
2C C L 39 1463.6 14.81 8.0389
2C C L 46 1401.75 14.29 8.1202
2C C L 53 1027.85 17.36 7.7855
2C C L 60 - - -
2C C L 64 355.35 9.5 4.0621
2C C L 71 940.1 12.97 6.7602
2C C L 78 534.4 9.1529 4.4928
2C C L 85 - - -
2C C L 92 - - -
2C C L 96 - - -
2C C L 110 - - -
2C C L 124 - - -
2C C L 128 - - -
3C C MH -4 1635.8 11.11 7.5751
3C C MH 0 1325.95 12.77 7.3911
3C C MH 14 1751 14.59 9.1284
3C C MH 28 1998.65 16.37 8.6177
3C C MH 32 2091 15.75 9.4081
3C C MH 39 2285.45 15.27 9.205
3C C MH 46 1992.2 18.352 9.4816
3C C MH 53 1692.05 15.87 9.3942
3C C MH 60 1932.65 16.649 8.4942
3C C MH 64 1469.25 12.51 8.1045
3C C MH 71 2032 11.36 7.9046
3C C MH 78 1843.9 12.56 10.147
3C C MH 85 1395.55 15.95 -
3C C MH 92 1449.05 15.007 7.6175
3C C MH 96 1571.15 11.29 -
3C C MH 110 1017 12.89 7.419
3C C MH 124 1278.55 12.91 7.4489
3C C MH 128 1048.95 10.17 6.2501
4C C H -4 1420.95 11.96 9.3826
4C C H 0 1367.55 12.16 10.617
4C C H 14 1734.65 17.76 10.919
4C C H 28 2256.15 14.666 12.068
4C C H 32 2167.15 16.14 12.063
4C C H 39 2156.9 14.73 10.648
4C C H 46 1125.05 18.37 11.127
4C C H 53 2061.7 18.44 12.294
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
4C C H 60 1929.6 17.1 11.645
4C C H 64 1765.85 11.58 11.564
4C C H 71 1902.8 11.29 12.204
4C C H 78 1574.25 14.23 10.948
4C C H 85 2124.25 18.17 11.501
4C C H 92 1824.35 14.91 12.435
4C C H 96 2009 15.55 13.121
4C C H 110 1593.95 13.47 9.8792
4C C H 124 1093.75 13.41 9.9958
4C C H 128 1018.25 12.84 8.1353
5C C M -4 898.75 9.76 9.5474
5C C M 0 1197.3 13.89 10.307
5C C M 14 1372.2 14.05 9.9038
5C C M 28 1683.55 17.91 11.336
5C C M 32 1616.75 18.5 13.843
5C C M 39 674.15 10.989 7.2387
5C C M 46 1565.9 17.182 -
5C C M 53 1634.05 18.23 11.625
5C C M 60 1791.7 15.3 12.641
5C C M 64 1530.5 14.88 11.625
5C C M 71 1417 22.89 10.776
5C C M 78 1706.85 15.9 10.581
5C C M 85 1474.65 11.95 10.038
5C C M 92 1154.1 16.38 11.882
5C C M 96 1270.5 16.28 10.359
5C C M 110 - - -
5C C M 124 1098.4 15.804 9.9595
5C C M 128 1080.5 11.4 8.7991
6C C H -4 1845.7 12.65 13.383
6C C H 0 1002.3 14.5 8.6886
6C C H 14 1765.7 17.09 13.076
6C C H 28 2054.75 16.48 12.086
6C C H 32 1626.3 17.78 14.289
6C C H 39 1750.9 17.43 -
6C C H 46 1851 17.517 -
6C C H 53 - - -
6C C H 60 - - -
6C C H 64 - - -
6C C H 71 - - -
6C C H 78 - - -
6C C H 85 - - -
6C C H 92 - - -
6C C H 96 - - -
6C C H 110 - - -
6C C H 124 - - -
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
6C C H 128 - - -
1D D M -4 1017.25 10.11 10.761
1D D M 0 848.9 10.92 8.1576
1D D M 14 1141.95 13.98 8.9346
1D D M 28 1261.75 15.24 8.7854
1D D M 32 1292.6 13.53 8.663
1D D M 39 1472.3 - 8.7974
1D D M 46 974 11.49 9.6067
1D D M 53 907.15 13.35 8.4199
1D D M 60 1013.25 14.14 8.7137
1D D M 64 1175.8 9.79 7.7525
1D D M 71 1477.8 10.59 9.6715
1D D M 78 1058.35 12.32 9.3262
1D D M 85 876.7 12.675 8.7704
1D D M 92 - - -
1D D M 96 - - -
1D D M 110 - - -
1D D M 124 - - -
1D D M 128 - - -
2D D MH -4 805.55 13.45 10.611
2D D MH 0 1559.55 14.706 8.298
2D D MH 14 2016.15 16.904 10.073
2D D MH 28 1911.3 17.9 10.936
2D D MH 32 2349.05 21.628 12.476
2D D MH 39 567.1 9.3749 6.0429
2D D MH 46 1460.65 13.66 10.412
2D D MH 53 1587.95 13.72 11.94
2D D MH 60 1369.5 15.909 10.863
2D D MH 64 1393.65 12.136 -
2D D MH 71 2095.3 14.35 12.097
2D D MH 78 2197 13.81 14.028
2D D MH 85 2067.35 13.554 -
2D D MH 92 1689.55 15.3 12.181
2D D MH 96 1473.35 17.032 11.38
2D D MH 110 1741.45 16.11 11.777
2D D MH 124 1645.95 14.79 -
2D D MH 128 1368.55 16.882 11.111
3D D H -4 1529 12.23 -
3D D H 0 1443.45 10.97 8.4989
3D D H 14 1947.8 10.268 9.7806
3D D H 28 1977.8 10.51 9.3027
3D D H 32 2311.4 16.617 10.289
3D D H 39 2280.9 11.41 8.8321
3D D H 46 1382.2 13.35 8.8051
3D D H 53 2007 13.21 -
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
3D D H 60 2149.7 16.217 9.2407
3D D H 64 1854.75 9.73 7.4349
3D D H 71 2142.45 11.008 8.0811
3D D H 78 1619.25 11.94 9.0788
3D D H 85 1681.7 13.59 -
3D D H 92 2221.35 12.04 8.6774
3D D H 96 1887.65 11.313 -
3D D H 110 - - -
3D D H 124 - - -
3D D H 128 - - -
4D D MH -4 1796.45 15.75 10.447
4D D MH 0 1693.1 15.6 -
4D D MH 14 1911.65 16.63 11.224
4D D MH 28 2492.8 15.73 -
4D D MH 32 2134.1 14.85 -
4D D MH 39 2289.9 15.2 12.095
4D D MH 46 1451 16.51 10.431
4D D MH 53 1768.35 18.43 11.156
4D D MH 60 1936.75 18.383 -
4D D MH 64 1713.65 12.63 -
4D D MH 71 2381.85 14.416 12.139
4D D MH 78 1791.8 15.72 -
4D D MH 85 1450.65 17.15 10.775
4D D MH 92 1755.35 15.18 -
4D D MH 96 1605.2 15.34 10.872
4D D MH 110 1662.95 14.65 11.782
4D D MH 124 - - -
4D D MH 128 - - -
5D D H -4 1054.2 9.21 10.527
5D D H 0 1316.55 8.93 7.7547
5D D H 14 1892.35 11.91 11.416
5D D H 28 831.4 10.5 7.2272
5D D H 32 1374.05 15.724 10.884
5D D H 39 1717.5 14.51 10.175
5D D H 46 1625.25 14.65 11.213
5D D H 53 1785.65 14.26 11.191
5D D H 60 1836.4 13.46 10.555
5D D H 64 1131.5 10.966 8.5025
5D D H 71 1236.1 16.424 10.537
5D D H 78 1538.3 12.12 10.533
5D D H 85 1701.65 12.403 9.4215
5D D H 92 1590.3 15.59 -
5D D H 96 1491.8 12.6 10.697
5D D H 110 - - -
5D D H 124 1165.4 10.94 8.7537
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Horse Diet Group Day PICP (ng/ml) ICTP (ng/mL) Osteocalcin (ng/mL)
5D D H 128 962.6 8.52 7.153
6D D MH -4 1196.85 10 9.2562
6D D MH 0 1174.3 10.62 -
6D D MH 14 1776.7 11.51 10.117
6D D MH 28 1604.95 - 9.6897
6D D MH 32 1441.95 15.01 10.381
6D D MH 39 1112.45 13.57 9.595
6D D MH 46 1607.9 14.71 10.394
6D D MH 53 1579.55 14.45 -
6D D MH 60 1578.35 13.25 10.854
6D D MH 64 1430.7 10.1 8.9926
6D D MH 71 1539.25 14.13 10.384
6D D MH 78 1800.65 12.26 -
6D D MH 85 1382.05 8.69 9.1642
6D D MH 92 1090.8 12.35 9.9582
6D D MH 96 1065.35 11.48 9.4676
6D D MH 110 1380.65 12.05 9.5305
6D D MH 124 850.7 9.84 7.7835
6D D MH 128 734 10.49 9.3437
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7A.  ANOVA TABLE FOR ICTP 
 
 
 
 
 
7B.  MEANS TABLE FOR ICTP BY GROUPINGS 
 
 
 
 
Source df SS MS F-value P-value
ICTP
  Model 71 816.912 11.506 1.83 0.0004
  Group 3 383.060 12.695 2.01 0.1124
  Day 17 570.054 33.533 5.32 0.0000
  Group *Day 51 192.452 3.774 0.60 0.9851
  Error 249 1568.808 6.300
  Total 320 2385.720 7.455
Normalized ICTP
  Model 71 913.776 12.870 2.29 0.0000
  Group 3 173.282 57.761 10.26 0.0000
  Day 17 559.385 32.905 5.85 0.0000
  Group *Day 51 199.081 3.904 0.69 0.9412
  Error 249 1401.577 5.629
  Total 320 2315.354 7.235
Low Moderate Mod-High High
ICTP, ng/ml 13.30 13.69 14.31 13.33
  SEM 0.35 0.31 0.30 0.25
∆ICTP, ng/ml 3.47a 3.06a,c 1.67b 2.2b,c
  SEM 0.32 0.28 0.27 0.27
a,b,cColumn means not sharing common superscripts differ (P<0.05)
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7C.  FIXED EFFECTS MODEL OF DIETARY CA ON SERUM ICTP 
 
Variable Coefficient SE t P
cagd -0.05 0.02 -3.12 0.002
int1 16.80 1.01 16.61 0.000
int2 17.44 1.00 17.49 0.000
int3 18.05 1.00 18.06 0.000
int4 17.70 1.02 17.31 0.000
int5 14.15 1.00 14.09 0.000
int6 16.49 1.02 16.14 0.000
int7 15.54 1.02 15.21 0.000
int8 15.19 1.06 14.38 0.000
int9 17.10 1.07 16.01 0.000
int10 17.04 1.07 15.96 0.000
int11 16.53 1.10 15.03 0.000
int12 16.11 1.09 14.72 0.000
int13 15.41 1.09 14.08 0.000
F( 14,   189) 477.89
Prob > F 0
Adj R-squared 0.9705
Number of obs 203  
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8A.  ANOVA TABLE FOR PICP 
 
 
 
 
 
8B.  MEANS TABLE FOR PICP 
 
 
 
 
Source df SS MS F-value P-value
PICP
  Model 71 23892084.60 336508.234 2.98 0.0000
  Group 3 9261961.08 3087320.360 27.30 0.0000
  Day 17 8870328.74 521784.043 4.61 0.0000
  Group *Day 51 5208570.65 102128.836 0.90 0.6612
  Error 251 28389393.00 113105.152
  Total 322 52281477.60 162364.837
Normalized PICP
  Model 71 16646861.100 234462.832 1.63 0.0034
  Group 3 2795055.590 931685.196 6.46 0.0003
  Day 17 8280761.970 487103.645 3.38 0.0000
  Group *Day 51 5500992.670 107862.601 0.75 0.8926
  Error 251 36173071.500 144115.823
  Total 322 52819932.600 164037.058
Low Moderate Mod-High High
PICP, ng/ml 1180.48a 1382.08b 1619.26c 1589.99c
  SEM 41.17 34.21 44.65 41.71
∆PICP, ng/ml 144.82a,b 103.41a 275.01b,c 315.53c
  SEM 40.20 42.87 53.95 39.30
a,b,cColumn means not sharing common superscripts differ (P<0.05)
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8C.  FIXED EFFECTS MODEL OF DIETARY CA ON SERUM PICP 
 
Variable Coefficient SE t P
cagd 8.78 2.34 3.75 0.000
int1 1069.37 146.19 7.31 0.000
int2 983.84 146.19 6.73 0.000
int3 1169.92 146.59 7.98 0.000
int4 1118.42 149.97 7.46 0.000
int5 877.58 147.28 5.96 0.000
int6 1150.53 149.81 7.68 0.000
int7 1114.01 149.81 7.44 0.000
int8 941.36 154.85 6.08 0.000
int9 964.99 156.58 6.16 0.000
int10 963.61 156.58 6.15 0.000
int11 954.31 161.23 5.92 0.000
int12 826.24 160.48 5.15 0.000
int13 539.90 160.48 3.36 0.001
F( 14,   190) 245.32
Prob > F 0
Adj R-squared 0.9476
Number of obs 204  
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9.  ANOVA TABLE FOR OSTEOCALCIN 
 
 
 
Source df SS MS F-value P-value
Osteocalcin
  Model 71 268.038 3.775 0.89 0.7224
  Group 3 44.919 14.973 3.51 0.0161
  Day 17 127.064 7.474 1.75 0.0356
  Group *Day 51 103.058 2.021 0.47 0.9990
  Error 220 938.109 4.264
  Total 291 1206.148 14.145
Normalized osteocalcin
  Model 71 223.507 3.148 1.10 0.3018
  Group 3 17.488 5.829 2.04 0.1099
  Day 17 103.420 6.084 2.13 0.0077
  Group *Day 51 91.417 1.792 0.63 0.9734
  Error 175 499.808 2.856
  Total 246 723.315 2.940
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